Literature DB >> 28887636

MiR-184 Retarded the Proliferation, Invasiveness and Migration of Glioblastoma Cells by Repressing Stanniocalcin-2.

Linsen Feng1,2, Jianhua Ma1, Haiming Ji1, Yichun Liu1, Weixing Hu3.   

Abstract

To investigate the repression of miR-184 on Stanniocalcin-2 (STC2) and how this axis affects the propagation, invasiveness and migration ability of glioblastoma cells. RT-PCR was employed to determine the miR-184 and STC2 mRNA expression both in tissues and cells. Western blot was employed to determine the protein expression levels. The cells were transfected via lipofection. MTT, colony formation, invasion and scratch healing assays were conducted to study the propagation, invasiveness and migratory ability of glioblastoma cells, respectively. The dual luciferase reporter gene assay was conducted to determine whether miR-184 could directly bind to STC2 mRNA 3'UTR. MiR-184 was under-expressed whereas STC2 was over-expressed in glioblastoma tissues and cell line. The up-regulation of miR-184 significantly suppressed the propagation, migratory ability and invasion of glioblastoma cells, whereas the over-expression of STC2 restored this effect. MiR-184 was confirmed to directly target STC2. MiR-184 could retard the propagation, invasiveness and migratory ability of glioblastoma cells by suppressing STC2.

Entities:  

Keywords:  Glioblastoma; Invasion; Migration; Proliferation; STC2; miR-184

Mesh:

Substances:

Year:  2017        PMID: 28887636     DOI: 10.1007/s12253-017-0298-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  37 in total

1.  Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patients.

Authors:  Jingyuan Su; Bingyu Guo; Tingting Zhang; Kanwen Wang; Xiaoming Li; Guobiao Liang
Journal:  Tumour Biol       Date:  2015-03-18

2.  Inhibitory effect of miR-184 on the potential of proliferation and invasion in human glioma and breast cancer cells in vitro.

Authors:  Ren Feng; Lei Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  MicroRNA-485-5p suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting stanniocalcin 2.

Authors:  Guo-Xiao Guo; Quan-Ying Li; Wan-Li Ma; Zhao-Hui Shi; Xue-Qun Ren
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 4.  The stanniocalcin family of proteins.

Authors:  Graham F Wagner; Gabriel E Dimattia
Journal:  J Exp Zool A Comp Exp Biol       Date:  2006-09-01

5.  Increased expression of stanniocalcin 2 is associated with tumor progression after radiotherapy in patients with cervical carcinoma.

Authors:  Xiao-Jian Shen; Ke Gu; Jian-Ping Shi; Jian-Qin Yao; Jin-Chang Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

6.  Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties.

Authors:  Daisuke Ito; John R Walker; Charlie S Thompson; Isabella Moroz; William Lin; Margaret L Veselits; Antoine M Hakim; Allen A Fienberg; Gopal Thinakaran
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

7.  Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.

Authors:  Bastian Malzkorn; Marietta Wolter; Franziska Liesenberg; Michael Grzendowski; Kai Stühler; Helmut E Meyer; Guido Reifenberger
Journal:  Brain Pathol       Date:  2009-09-19       Impact factor: 6.508

8.  Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways.

Authors:  Alice Y S Law; Chris K C Wong
Journal:  Mol Cell Endocrinol       Date:  2013-05-07       Impact factor: 4.102

9.  microRNA-184 functions as tumor suppressor in renal cell carcinoma.

Authors:  Zhengming Su; Duqun Chen; Yifan Li; Enpu Zhang; Zuhu Yu; Ting Chen; Zhimao Jiang; Liangchao Ni; Shangqi Yang; Yaoting Gui; Jiongxian Ye; Yongqing Lai
Journal:  Exp Ther Med       Date:  2015-01-21       Impact factor: 2.447

10.  STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.

Authors:  Haixiao Wang; Kuangjie Wu; Yuan Sun; Yandong Li; Mingyu Wu; Qian Qiao; Yuanjiang Wei; Ze-Guang Han; Bing Cai
Journal:  BMB Rep       Date:  2012-11       Impact factor: 4.778

View more
  7 in total

1.  MicroRNA-184 negatively regulates corneal epithelial wound healing via targeting CDC25A, CARM1, and LASP1.

Authors:  Qiongjie Cao; Weiwei Xu; Weiwei Chen; Dewei Peng; Qi Liu; Jing Dong; Peter S Reinach; Dongsheng Yan
Journal:  Eye Vis (Lond)       Date:  2020-08-01

2.  Functional Analysis of the 3' Untranslated Region of the Human GRIN1 Gene in Regulating Gene Expression in vitro.

Authors:  Yong-Ping Liu; Xue Wu; Jing-Hua Meng; Jun Yao; Bao-Jie Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-12       Impact factor: 2.570

3.  A Novel Mechanism of BAM8-22 Inhibiting Microglia Activation: Represses CX3CR1 Expression via Upregulating miR-184.

Authors:  Aitao Wang; Muer Tie; Dongmei Guo; Na Wu; Shanglong Yao; Limei Yan; Xingsheng Zhao
Journal:  J Mol Neurosci       Date:  2019-12-12       Impact factor: 3.444

4.  Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.

Authors:  Tiancheng Li; Yao Qin; Zhen Zhen; Hong Shen; Tiechuan Cong; Erik Schiferle; Shuifang Xiao
Journal:  Cell Prolif       Date:  2019-07-11       Impact factor: 6.831

5.  Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.

Authors:  Ming Sun; Sihan Chen; Min Fu
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

Review 6.  Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.

Authors:  Shuo Qie; Nianli Sang
Journal:  J Exp Clin Cancer Res       Date:  2022-05-02

7.  Effect of miR-184 on Proliferation and Apoptosis of Pancreatic Ductal Adenocarcinoma and Its Mechanism.

Authors:  Shentao Li; He Li; Weiwei Ge; Kai Song; Chunyu Yuan; Ran Yin
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.